Elemental Impurities– An Update Kahkashan Zaidi, Ph.D. General chapters USP.

Slides:



Advertisements
Similar presentations
Dr. Birgit Schmauser, BfArM, Bonn
Advertisements

When is Excipient Reduced Testing Appropriate?
Welcome to the USP User Forum Istanbul, Turkey January 17, 2013.
2-4 ICH Quality Guidances: an overview
USP Monographs Roger L. Williams, M.D. CEO/Chair, Council of Experts 6 th Annual Science and Standards Symposium January 16, 2013 Istanbul.
CONFERENCE ON “ FOOD ADDITIVES : SAFETY IN USE AND CONSUMER CONCERNS“ JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY NAIROBI, 24 JUNE 2014.
Impurities in New Drug Substances ICH Topic Q3A (R) – Revised Guidelines in Oct الشوائب في الأدوية الجديدة.
World Health Organization
Michael H. Dong MPH, DrPA, PhD readings Human Exposure Assessment II (8th of 10 Lectures on Toxicologic Epidemiology)
ECOLOGICAL STANDARDS OF MARINE ENVIRONMENT QUALITY DEVELOPED BY: Research Organization “Ukrainian Scientific Centre of the Ecology of Sea” (RO UkrSCES)
Determine impurity level in relevant batches1
Quality control of raw materials In-process control
Proposed Rules under the FDA Food Safety Modernization Act
The Standard of Quality TM USP Controls on Lead in Pharmaceuticals Heavy Metals – USP Perspective Darrell R. Abernethy, MD, Ph.D. Chief Science Officer.
CE Introduction to Environmental Engineering and Science Readings for This Class: Chapter 4 O hio N orthern U niversity Introduction Chemistry,
FAO/WHO CODEX TRAINING PACKAGE
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
1 FDA Survey of Lead in Pharmaceuticals John F. Kauffman, PhD R&D Team Leader CDER, Division of Pharmaceutical Analysis ACPS-CP Meeting July 22,2008.
Determination of Heavy Metals in Traditional Chinese Herbs & Chinese Proprietary Medicines in Victoria, Australia – How Safe Are They? Thomas Cheung Chun.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Nanomaterials Issue Paper Standard 61 Joint Committee Meeting December, 2013.
Understanding ISO 22000:2005 TCISys.com.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Forging Partnerships on Emerging Contaminants November 2, 2005 John Vandenberg Associate Director for Health National Center for Environmental Assessment.
FAO/WHO Codex Training Package Module 2.8 FAO/WHO CODEX TRAINING PACKAGE SECTION TWO – UNDERSTANDING THE ORGANIZATION OF CODEX 2.8 Is there a format for.
The Minerals & Supplementation Chapters 11 & 12. The Minerals – An Overview  Major vs. trace minerals  Variation in amounts needed  Inorganic elements.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
Foreign Supplier Verification Programs Supplemental Proposal 1.
INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT. INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT Indian Pharmacopoeia Commission (IPC) Vision The IPC is committed.
FAO/WHO Codex Training Package Module 4.3 FAO/WHO CODEX TRAINING PACKAGE SECTION FOUR – SCIENTIFIC BASIS FOR CODEX WORK 4.3 What is JECFA?
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on impurities Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM, Council.
September 18, 1998 State of Illinois Rules and Regulations Tiered Approach to Corrective Action (TACO) Presented by The Great Plains/Rocky Mountain Technical.
1 FDA Guidance for Industry: ANDAs: Impurities in Drug Substances Published by US FDA’s Center for Drug Evaluation and Research June 2009.
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
William Telliard U.S. EPA Office of Science and Technology
Transition Elements Chapter 5 Section 3. The Metals in the Middle  Remember from Section 1 that the Transition elements are in groups 3-12  Transition.
I RIS E NVIRONMENTAL Independent Review of Documents Pertaining to the Lehigh Southwest Cement Permanente Facility Rob Balas & John McLaughlin February.
FDA Preventive Control Regulation Ernest Julian, Ph.D., Chief Office of Food Protection RI Department of Health AFDO 2014.
Connie Brower NC DENR Division of Water Resources.
VICH Guidelines: Stability Testing of New Veterinary Drug Substances and Medicinal Products Mai Huynh U.S. FDA Center for Veterinary Medicine Washington.
Postharvest/Biochemistry Unit H HARRY OKYERE. LEVELS OF MERCURY, LEAD AND CADMIUM IN CANNED FISH MARKETED IN GHANA.
1. Consumers, Health, Agriculture and Food Executive Agency Risk assessment with regard to food and feed safety Risk analysis Why risk assessment in the.
USP: Water for Pharmaceutical Purposes NCSLI – Metrological Traceability in Pure Water Testing August 22, 2011 Antonio Hernandez-Cardoso Senior Scientific.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Heavy Metals: Regulatory Aspects DIA-SIG RA-CMC working group 15Mar12 Anders Neil Principal Consultant PAREXEL Consulting.
BSB Biomanufacturing CHAPTER 11 GMP – Pharmaceutical Water
OBJECTIVES Understanding what food chemicals are?
Anniston PCB Site Review of Risk Assessments for OU-1/OU-2
Pharmaceutical Quality Control & current Good Manufacturing Practice
Aquatic Life Metals Criteria Under Development in OW
Status of EPA Method 1631 for the Determination of Low-Level Mercury
EPA Method Equivalency
Triennial Review of Water Quality Standards Proposed Rulemaking
Updates to Expedited Review Procedures
Arsenic Acceptable Ambient Level Revision
IPPC second consultation 1 July to 30 September 2018
Changes to Exempt Categories
Analytical Method Validation
Updates to Expedited Review Procedures
Environmental sampling and monitoring
Report of Proceedings Surface Water Quality Standards Triennial Review Environmental Management Commission November 13, 2014 Steve Tedder – EMC Hearing.
Draft examples of possible GES Decision criteria Descriptor 9
Traceable OTA Performance Testing Presentation
TCEQ Environmental Trade Fair Water Quality Division
GL18 (R) – Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substance and Excipients.
The European Pharmacopoeia and Pharmeuropa
Quality guidelines on impurities
Quality guidelines on impurities
VICH GL 54, Studies to evaluate the safety of residues of veterinary drugs in human food: General approach to establish an Acute Reference Dose (ARfD)
Guideline for Elemental Impurities ICH Q3D(R)
Presentation transcript:

Elemental Impurities– An Update Kahkashan Zaidi, Ph.D. General chapters USP

Heavy Metals - Background  Introduced in USP VIII (1905)  Consists of three procedures, all involving –Sulfide precipitation of metals –Visual comparison to lead standards  Methods in the EP and JP are similar to the USP methods

Activities--- and USP Stimuli Article in PF 34(5) for public comment (November, 2008) USP published draft revisions for comment in PF 36(1), January, 2010: –Elements and limits chapter –Methodology chapter –Dietary Supplement chapter –Stimuli article with rationales for limits –Stimuli article with responses to comments on PF 34(5) stimuli article Revisions in PF 37(3) Final chapters available on the USP website

 Revised to address comments received.  Elements and limits essentially the same as the ICH- Q3D pre-stage 2 proposal.  Available on the USP website. Elemental Impurities – Limits

Proposed USP General Chapter Elemental Impurities-Limits

Toxicology USP approach to elemental impurity control is both health based and risk based Control metals that are toxic At limits that are toxicologically relevant At all times during a drug product’s shelf life With a risk-based approach as to what and when to test

Basics Applies to drug products –Drug substances –Excipients Does not apply to dietary supplements Does not apply to Veterinary products Does not apply to conventional vaccines Speciation is not addressed in this Chapter Procedures are specified in Elemental Impurities – Procedures

Elemental Impurities are: Environmental contaminants Catalysts They may be: Naturally occurring Added intentionally Introduced inadvertently –Through interactions with processing equipment –Through non-GMP routes A risk-based control strategy may assure compliance. However, compliance with the limits is required for all drug products at all times.

Elemental Impurities-Limits Element OralDaily Dose PDE a (µg/day) a ▪ Parenteral Daily Dose PDE (µg/day) ▪ Inhalational Daily Dose PDE (µg/day) LVP Component Limit (µg/g) Cadmium 5 ▪ ▪ 0.25 Lead 10 ▪ ▪ 0.5 Inorganic arsenic b b 15 ▪ Inorganic Mercury b b Iridium Osmium Palladium Platinum Rhodium Ruthenium Chromium 250 ▪ ** ▪ * Molybdenum 250 ▪ ▪ 1.0 Nickel 250 ▪ ▪ 5.0 Vanadium 250 ▪ ▪ 1.0 Copper 2500 ▪ Manganese a PDE = Permissible Daily Exposure based on a 50Kg person. b See Speciation section. * not a safety concern

Options to Determine Content Drug Product Analysis Option –Sample and measure dosage form –Scale results to daily dose Summation Option –Sample and measure all components –Validate process will add no additional impurities –Sum each metal and scale to daily dose Individual Component Approach for LVP

Proposed USP General Chapter Elemental Contaminants in Dietary Supplements

Draft Basics Applies to Dietary Supplements –Dietary Ingredients –Excipients Does not apply to drug products Procedures in Elemental Impurities – Procedures are specified Speciation is critical for Dietary Supplements –Arsenic and Mercury procedures addressed in this Chapter Only “the big four” Elemental Impurities considered

Elemental Contaminants in Dietary Supplements Element PDE a (µg/day) Arsenic (inorganic) c c 15 Cadmium5 Lead10 Mercury (total)15 Methylmercury (as Hg) 2 a Permitted Daily Exposure (PDE) is derived from the Provisional Tolerable Weekly Intake (PTWI) that is recommended by the Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO) by subtracting the daily exposure (μg/day) to each elemental contaminant from air, food, and drinking water. A body weight of 50 kg and a safety factor are used to calculate the PDE.

Proposed USP General Chapter Elemental Impurities – Procedures

Elemental Impurities - Procedures –Definitions –Compendial Procedures Procedure 1: ICP-OES Procedure 2: ICP-MS –Validation Limit Procedures Quantitative Procedures –Calculations and Reporting –Comment on Method Verification per

Procedure Validation Requirements Limit Procedure: –Detectability –Precision (For Instrumental Methods) –Specificity

Procedure Validation Requirements Quantitative Procedure: –Accuracy –Detectability –Precision Repeatabiltiy Ruggedness –Specificity –LOQ –Range –Linearity

Procedure Validation Requirements Defines a procedure acceptance criteria Validation criteria for alternative procedures and Verification criteria for compendial procedures are identical

Implementation Chapters and will appear in Second Supplement to USP35 (official Dec 1, 2012). Will be implemented through General Notices with a delayed implementation date of May 1, 2014 All references to USP general chapter Heavy Metals will be removed from the monographs in USP37.

Questions?